Showing 51 - 58 of 58
Obscene rich list
Oped, Postbag, Published on 10/07/2021
» Re: "Thailand's richest 2021 list", (BP, July 9).
Mass jab hopes a crucial test for Prayut
News, Veera Prateepchaikul, Published on 31/05/2021
» Despite reassurances from Prime Minister Prayut Chan-o-cha and Public Health Minister Anutin Charnvirakul that the mass Covid-19 vaccinations for people over 60 and those suffering from seven non-communicable underlying diseases across the country will proceed as scheduled on June 7, scepticism remains strong among many about whether this administration can still be trusted after repeated blunders in the handling of the pandemic.
BioNTech Founders Expect Covid-19 Pandemic to Last Until Mid-2022
Business, Published on 06/05/2021
» The surge of coronavirus infections in developing countries such as India amid a relative scarcity of vaccine supply means that the pandemic will keep spreading until mid-2022, according to the inventors of the first Covid-19 vaccine authorized in the West.
Headline 'not racist'
Oped, Postbag, Published on 05/05/2021
» Re: "Racist' headline irks", (PostBag, May 3).
Pfizer jab not here yet, says FDA
Gary Boyle, Published on 06/05/2021
» The Food and Drug Administration (FDA) has dismissed a claim made online by ex-prime minister Thaksin Shinawatra in which he said the Pfizer vaccine was already in Thailand for use among a certain group of people.
Local AZ vaccine 'fit for use'
Gary Boyle, Published on 28/04/2021
» Samples of AstraZeneca vaccine licensed to be produced locally by Siam Bioscience have passed the standard set by the Department of Medical Sciences (DMS).
Indonesian businesses join jab drive
Asia focus, Ismira Lutfia Tisnadibrata, Published on 15/03/2021
» More than 9,000 private companies in Indonesia are gearing up to inoculate their employees and their family members in a bid to revive productivity that has been severely curtailed by the Covid-19 pandemic.
US vaccine 94.5% effective
Gary Boyle, Published on 17/11/2020
» US firm Moderna on Monday announced its experimental vaccine against Covid-19 was 94.5% effective, marking a second major breakthrough in the vaccine hunt.